Cargando…
Small Molecule NF-κB Pathway Inhibitors in Clinic
Nuclear factor kappa B (NF-κB) signaling is implicated in all major human chronic diseases, with its role in transcription of hundreds of gene well established in the literature. This has propelled research into targeting the NF-κB pathways for modulating expression of those genes and the diseases m...
Autores principales: | Ramadass, Venkataramanan, Vaiyapuri, Thamilselvan, Tergaonkar, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404026/ https://www.ncbi.nlm.nih.gov/pubmed/32708302 http://dx.doi.org/10.3390/ijms21145164 |
Ejemplares similares
-
NFκB drives TERT promoter reactivation in cancer
por: Tergaonkar, Vinay
Publicado: (2015) -
Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology
por: Tong, Louis, et al.
Publicado: (2014) -
Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020) -
Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression
por: Puar, Yu Rou, et al.
Publicado: (2018) -
Predicting the points of interaction of small molecules in the NF-κB pathway
por: Patel, Yogendra, et al.
Publicado: (2011)